Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018 2019 2020

Details for Mechanism ID: 18511
Country/Region: Kenya
Year: 2017
Main Partner: Christian Health Association of Kenya
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: HHS/CDC
Total Funding: $8,009,304 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Orphans and Vulnerable Children (HKID) $207,674
Care: TB/HIV (HVTB) $505,567
Testing: HIV Testing and Counseling (HVCT) $868,680
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $491,215
Treatment: Adult Treatment (HTXS) $5,442,281
Treatment: Pediatric Treatment (PDTX) $493,887
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV <10, Female, Physical and/or Emotional Violence 2018 423
GEND_GBV <10, Female, Sexual Violence (Post-Rape Care) 2018 154
GEND_GBV <10, Male, Physical and/or Emotional Violence 2018 58
GEND_GBV <10, Male, Sexual Violence (Post-Rape Care) 2018 22
GEND_GBV 10-14, Female, Physical and/or Emotional Violence 2018 423
GEND_GBV 10-14, Female, Sexual Violence (Post-Rape Care) 2018 154
GEND_GBV 10-14, Male, Physical and/or Emotional Violence 2018 59
GEND_GBV 10-14, Male, Sexual Violence (Post-Rape Care) 2018 22
GEND_GBV 15-19, Female, Physical and/or Emotional Violence 2018 506
GEND_GBV 15-19, Female, Sexual Violence (Post-Rape Care) 2018 186
GEND_GBV 15-19, Male, Physical and/or Emotional Violence 2018 68
GEND_GBV 15-19, Male, Sexual Violence (Post-Rape Care) 2018 25
GEND_GBV 20-24, Female, Physical and/or Emotional Violence 2018 506
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2018 186
GEND_GBV 20-24, Male, Physical and/or Emotional Violence 2018 68
GEND_GBV 20-24, Male, Sexual Violence (Post-Rape Care) 2018 25
GEND_GBV 25-49, Female, Physical and/or Emotional Violence 2018 210
GEND_GBV 25-49, Female, Sexual Violence (Post-Rape Care) 2018 78
GEND_GBV 25-49, Male, Physical and/or Emotional Violence 2018 28
GEND_GBV 25-49, Male, Sexual Violence (Post-Rape Care) 2018 12
GEND_GBV 50+, Female, Physical and/or Emotional Violence 2018 41
GEND_GBV 50+, Female, Sexual Violence (Post-Rape Care) 2018 14
GEND_GBV 50+, Male, Physical and/or Emotional Violence 2018 5
GEND_GBV 50+, Male, Sexual Violence (Post-Rape Care) 2018 2
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 1,292
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 11,594
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 3,157
GEND_GBV Number of people receiving post-GBV care 2018 14,771
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 357,751
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2018 105
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2018 940
HTS_TST Service Delivery Point (Facility) ANC: 25-49, Negative 2018 2,335
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2018 260
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2018 143
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2018 101
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2018 77
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2018 54
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2018 75
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2018 55
HTS_TST Service Delivery Point (Facility) Index: 25-49, Female, Negative 2018 108
HTS_TST Service Delivery Point (Facility) Index: 25-49, Male, Negative 2018 92
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2018 27
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2018 14
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2018 10
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2018 124
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2018 14
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2018 21
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2018 28
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2018 38
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2018 77
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2018 34
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Female, Negative 2018 307
HTS_TST Service Delivery Point (Facility) Inpatient: 25-49, Male, Negative 2018 139
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2018 140
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2018 145
HTS_TST Service Delivery Point (Facility) Malnutrition: Negative 2018 15
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 2,537
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 697
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 698
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 1,102
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 840
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 1,803
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 937
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 7,177
HTS_TST Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 4,465
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 2,046
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 1,844
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2018 4,409
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2018 9
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2018 1
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2018 2
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2018 2
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2018 4
HTS_TST Service Delivery Point (Facility) TB: 25-49, Female, Negative 2018 13
HTS_TST Service Delivery Point (Facility) TB: 25-49, Male, Negative 2018 19
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2018 1
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2018 3
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2018 296
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2018 207
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2018 473
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2018 338
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Female, Negative 2018 1,292
HTS_TST Service Delivery Point (Facility) VCT: 25-49, Male, Negative 2018 833
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2018 281
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2018 239
HTS_TST Service Delivery Point (Facility)Other PITC: <1, Negative 2018 33
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Female, Negative 2018 1,908
HTS_TST Service Delivery Point Agg Age (Facility) Index: <15, Male, Negative 2018 1,749
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 3,864
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 2,350
HTS_TST Service Delivery Point by Agg Age (Facility) ANC: <15, Negative 2018 2
HTS_TST Service Delivery Point by Agg Age (Facility) ANC: 15+, Negative 2018 36,416
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Negative 2018 1,625
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Negative 2018 2,486
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 14,049
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 9,176
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Negative 2018 15,196
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Negative 2018 15,965
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 108,311
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 65,582
HTS_TST Service Delivery Point by Agg Age (Facility) TB: <15, Female, Negative 2018 35
HTS_TST Service Delivery Point by Agg Age (Facility) TB: <15, Male, Negative 2018 47
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Negative 2018 409
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Negative 2018 318
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Negative 2018 23
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Negative 2018 62
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Negative 2018 18,844
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Negative 2018 12,481
HTS_TST Sum of Test Result disaggregates 2018 7,841
HTS_TST_POS By Test Result: Positive 2018 7,841
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2018 61
HTS_TST_POS Service Delivery Point (Facility) ANC: 25-49, Positive 2018 245
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2018 3
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2018 7
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2018 10
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Female, Positive 2018 14
HTS_TST_POS Service Delivery Point (Facility) Index: 25-49, Male, Positive 2018 13
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Inpatient: <1, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Female, Positive 2018 24
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 25-49, Male, Positive 2018 13
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2018 5
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 6
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 35
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2018 13
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 239
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 132
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 461
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 240
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2018 34
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 17
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2018 6
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Female, Positive 2018 13
HTS_TST_POS Service Delivery Point (Facility) TB: 25-49, Male, Positive 2018 8
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2018 8
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2018 27
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2018 14
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Female, Positive 2018 90
HTS_TST_POS Service Delivery Point (Facility) VCT: 25-49, Male, Positive 2018 56
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2018 4
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2018 5
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Female, Positive 2018 15
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: <15, Male, Positive 2018 10
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 108
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 64
HTS_TST_POS Service Delivery Point by Agg Age (Facility) ANC: 15+, Positive 2018 1,214
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Female, Positive 2018 13
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: <15, Male, Positive 2018 13
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 185
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 110
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Positive 2018 129
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Positive 2018 114
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 1,966
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 973
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: <15, Female, Positive 2018 1
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: <15, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Positive 2018 72
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Positive 2018 51
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Positive 2018 633
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Positive 2018 327
OVC_SERV Age/Sex: <1 2018 8
OVC_SERV Age/Sex: 1-9 2018 1,437
OVC_SERV Age/Sex: 10-14 Female 2018 675
OVC_SERV Age/Sex: 10-14 Male 2018 665
OVC_SERV Age/Sex: 15-17 Female 2018 406
OVC_SERV Age/Sex: 15-17 Male 2018 371
OVC_SERV By: Age/sex: 18-24 Female 2018 188
OVC_SERV By: Age/sex: Male 18-24 2018 214
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2018 3,965
OVC_SERV Program Completion: Active 2018 3,568
OVC_SERV Program Completion: Exited without graduation 2018 75
OVC_SERV Program Completion: Graduation 2018 199
OVC_SERV Program Completion: Transferred 2018 123
OVC_SERV Sum of Age/Sex disaggregates 2018 2,117
PMTCT_ART Already on ART at beginning of current pregnancy 2018 1,041
PMTCT_ART New on ART 2018 766
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 1,807
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 44,108
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 1,737
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 400
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 1,331
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 3
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 1
PMTCT_EID Unknown, <= 2 months 2018 2
PMTCT_STAT By Age (Numerator): 10-14 2018 10
PMTCT_STAT By Age (Numerator): 15-19 2018 1,677
PMTCT_STAT By Age (Numerator): 20-24 2018 12,650
PMTCT_STAT By Age (Numerator): 25-49 2018 29,771
PMTCT_STAT By Number of known positives: 15-19 2018 9
PMTCT_STAT By Number of known positives: 20-24 2018 210
PMTCT_STAT By Number of known positives: 25-49 2018 822
PMTCT_STAT By Number of new negative: 10-14 2018 10
PMTCT_STAT By Number of new negative: 15-19 2018 1,655
PMTCT_STAT By Number of new negative: 20-24 2018 12,241
PMTCT_STAT By Number of new negative: 25-49 2018 28,387
PMTCT_STAT By Number of new positives: 15-19 2018 15
PMTCT_STAT By Number of new positives: 20-24 2018 194
PMTCT_STAT By Number of new positives: 25-49 2018 619
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 44,108
PMTCT_STAT_den By Age (Denominator): <15-19 2018 1,677
PMTCT_STAT_den By Age (Denominator): 10-14 2018 11
PMTCT_STAT_den By Age (Denominator): 20-24 2018 12,648
PMTCT_STAT_den By Age (Denominator): 25-49 2018 29,772
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 44
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 650
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 86
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 336
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 1,134
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 1,116
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 48
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 654
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 90
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 342
TB_PREV By Age/Sex (Numerator): <15, Female 2018 284
TB_PREV By Age/Sex (Numerator): <15, Male 2018 268
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 6,342
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 2,924
TB_PREV By Therapy type (Numerator): 6-12 Month IPT 2018 6,660
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 9,819
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 10,023
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 287
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 271
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 6,478
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 2,987
TB_PREV_den By Therapy type (Denominator): 6-12 Month IPT 2018 7,270
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 108
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,319
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 180
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 789
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 2,396
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 2,512
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 113
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,375
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 184
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 807
TX_CURR Age/Sex: <1 2018 11
TX_CURR Age/Sex: <1-9 2018 46
TX_CURR Age/Sex: 10-14 Female 2018 134
TX_CURR Age/Sex: 10-14 Male 2018 169
TX_CURR Age/Sex: 15-19 Female 2018 608
TX_CURR Age/Sex: 15-19 Male 2018 468
TX_CURR Age/Sex: 20-24 Female 2018 1,418
TX_CURR Age/Sex: 20-24 Male 2018 1,306
TX_CURR Age/Sex: 25-49 Female 2018 2,787
TX_CURR Age/Sex: 25-49 Male 2018 1,503
TX_CURR Age/Sex: 50+ Female 2018 637
TX_CURR Age/Sex: 50+ Male 2018 120
TX_CURR Aggregated Age/Sex: <15 Female 2018 1,755
TX_CURR Aggregated Age/Sex: <15 Male 2018 1,726
TX_CURR Aggregated Age/Sex: 15+ Female 2018 31,909
TX_CURR Aggregated Age/Sex: 15+ Male 2018 13,682
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 58,280
TX_CURR Sum of age/sex disaggregates 2018 1,076
TX_CURR Sum of Aggregated Age/Sex <15 2018 3,481
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 45,591
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 49,072
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 277
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 260
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 5,317
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 2,345
TX_NEW Breastfeeding status 2018 101
TX_NEW By Age/Sex: <1 2018 9
TX_NEW By Age/Sex: 1-9 2018 6
TX_NEW By Age/Sex: 10-14 Female 2018 14
TX_NEW By Age/Sex: 10-14 Male 2018 14
TX_NEW By Age/Sex: 15-19 Female 2018 64
TX_NEW By Age/Sex: 15-19 Male 2018 52
TX_NEW By Age/Sex: 20-24 Female 2018 371
TX_NEW By Age/Sex: 20-24 Male 2018 133
TX_NEW By Age/Sex: 25-49 Female 2018 1,073
TX_NEW By Age/Sex: 25-49 Male 2018 313
TX_NEW By Age/Sex: 50+ Female 2018 20
TX_NEW By Age/Sex: 50+ Male 2018 4
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 10,272
TX_NEW Pregnancy status 2018 622
TX_NEW Sum of Age/Sex disaggregates 2018 2,058
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 8,199
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 58,267
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 52,061
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 1,461
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 135
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 1,417
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 112
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 31,482
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 2,342
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 14,023
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 1,059
TX_PVLS Numerator: Indication: Routine 2018 48,413
TX_PVLS Numerator: Indication: Targeted 2018 3,648
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Routine 2018 69
TX_PVLS Numerator: Preg/BF by Indication: Breastfeeding Targeted 2018 3
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 618
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Targeted 2018 38
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 1,827
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 137
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 1,776
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 161
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 35,016
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 2,607
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 15,572
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 1,171
TX_PVLS_den Denominator: Indication: Routine 2018 54,191
TX_PVLS_den Denominator: Indication: Targeted 2018 4,076
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Routine 2018 69
TX_PVLS_den Denominator: Preg/BF by Indication: Breastfeeding Targeted 2018 3
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 623
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Targeted 2018 38
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 298
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 299
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 6,177
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 2,818
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 9,593
TX_RET Numerator by Status: Breastfeeding 2018 73
TX_RET Numerator by Status: Pregnant 2018 661
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 11,427
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 354
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 348
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 7,396
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 3,329
TX_RET_den Denominator by Status: Breastfeeding 2018 73
TX_RET_den Denominator by Status: Pregnant 2018 661
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 50,750
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 413
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 10
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 30
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 248
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 125
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 1,917
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 1,962
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 32,060
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 14,811
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 7,803
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Other (No Xpert) 2018 486
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 1,453
TX_TB_den Denominator: By Screen Result: Negative 2018 40,999
TX_TB_den Denominator: By Screen Result: Positive 2018 9,747
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 9,743
Cross Cutting Budget Categories and Known Amounts Total: $1,751,858
Gender: Gender Based Violence (GBV) $194,651
GBV Prevention
Implementation
Capacity building
Post GBV Care
Implementation
Capacity building
Human Resources for Health $1,557,207